Mark Biondo

946 citations

25 papers · 702 indexed · h-index 14

Impact in

Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in ⓘ

Genetics 6
- Chronic Lymphocytic Leukemia Research 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
Gastroenterology 3
- Celiac Disease Research and Management 3

Co-authors: Frank Alderuccio (6 shared papers)G Vairo (8 shared papers)Samantha J. Busfield (9 shared papers)Ban Hock Toh (2 shared papers)Jennifer M. Rolland (2 shared papers)Robyn E. O’Hehir (2 shared papers)Maria P. de Leon (1 shared paper)Belinda J. Hales (1 shared paper)
Journals: Blood (5 papers)Leukemia (2 papers)International Reviews of Immunology (2 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
Partner nations: Australia United States Germany

In The Last Decade

Mark Biondo

23 papers receiving 692 citations

Peers

Countries citing papers authored by Mark Biondo

Since Specialization

Citations

This map shows the geographic impact of Mark Biondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Biondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Biondo more than expected).

Fields of papers citing papers by Mark Biondo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Biondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Biondo. The network helps show where Mark Biondo may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Biondo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Biondo Line = papers co-authored together Mark Biondo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	House Dust Mite Sublingual Immunotherapy: The Role for Transforming Growth Factor–β and Functional Regulatory T Cells American Journal of Respiratory and Critical Care Medicine ·Robyn E. O’Hehir, Leanne M. Gardner, Maria P. de Leon, Belinda J. Hales, Mark Biondo, John Aubrey Douglass, Jennifer M. Rolland, Alessandra Sandrini	2009	138
2	Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC Leukemia ·Samantha J. Busfield, Mark Biondo, M. Wong, Hayley S. Ramshaw, E M Lee, Sukhen C. Ghosh, Hal Braley, Con Panousis, Andrew W. Roberts, Simon He, Danièl Thomas, Louis Fabri, G Vairo, Richard B. Lock, Angel F. López, Andrew D. Nash	2014	106
3	Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells Blood ·Eva Nievergall, Hayley S. Ramshaw, Agnes S. M. Yong, Mark Biondo, Samantha J. Busfield, G Vairo, Angel F. López, Timothy P. Hughes, Deborah L. White, Devendra Hiwase	2013	79
4	Local Transgenic Expression of Granulocyte Macrophage-Colony Stimulating Factor Initiates Autoimmunity The Journal of Immunology ·Mark Biondo, Zeyad Nasa, Aiden C.J. Marshall, Ban Hock Toh, Frank Alderuccio	2001	64
5	Animal Models of Human Disease: Experimental Autoimmune Gastritis—A Model for Autoimmune Gastritis and Pernicious Anemia Clinical Immunology ·Frank Alderuccio, John W. Sentry, Aiden C.J. Marshall, Mark Biondo, Ban Hock Toh	2002	50
6	TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy Leukemia ·Eva Nievergall, John Reynolds, Chung Hoow Kok, Dale B. Watkins, Mark Biondo, Samantha J. Busfield, G Vairo, Kathryn A. Fuller, Wendy N. Erber, Teresa Sadras, Randall Grose, David T Yeung, Angel F. López, Devendra Hiwase, Timothy P. Hughes, Deborah L. White	2016	38
7	CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission Blood Cancer Journal ·Liji Xie, Mark Biondo, Samantha J. Busfield, Andrea Arruda, Xinyun Yang, G Vairo, Mark D. Minden	2017	36
8	Functional immunoglobulin E cross‐reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens Clinical & Experimental Allergy ·Janet M. Davies, Thanh Dang, Astrid Voskamp, Alexander C. Drew, Mark Biondo, Michelle Phung, John W. Upham, Jennifer M. Rolland, Robyn E. O’Hehir	2011	31
9	A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus JCI Insight ·Shereen Oon, Huy Huynh, Tsin Yee Tai, Milica Ng, Katherine Monaghan, Mark Biondo, G Vairo, Eugene Maraskovsky, Andrew D. Nash, Ian P. Wicks, Nicholas J. Wilson	2016	26
10	Pharmacokinetic/pharmacodynamic modeling for dose selection for the first‐in‐human trial of the activated Factor XII inhibitor garadacimab (CSL312) Clinical and Translational Science ·Dipti Pawaskar, Xi Chen, Fiona Glassman, Frauke May, Anthony Roberts, Mark Biondo, Andrew McKenzie, Marc W. Nolte, William J. Jusko, Michael A. Tortorici	2021	16
11	A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML Blood ·Andrew W. Roberts, Simon He, Kenneth F. Bradstock, Mark Hertzberg, S. T. S. Durrant, David Ritchie, Ian D. Lewis, Paula Marlton, Andrew J. McLachlan, Trina Yeadon, Samantha J. Busfield, Megan Barnden, Roslyn Davis, Sarah Hosback, Danijela Mirosa, Mark Biondo, Simone Bamford, Mark DeWitte, Russell L. Basser	2008	16
12	Development and Characterization of an Anti-FXIIa Monoclonal Antibody for the Treatment of Hereditary Angioedema Journal of Allergy and Clinical Immunology ·Zhihui Cao, Mark Biondo, Veronika Rayzman, Matthew P. Hardy, Anne McDonald, Samantha J. Busfield, Marc W. Nolte, Michael Wilson, Andrew D. Nash, Con Panousis	2015	15
13	Organ-specific Autoimmunity in Granulocyte Macrophage-colony Stimulating Factor (GM-CSF) Deficient Mice Autoimmunity ·Frank Alderuccio, Mark Biondo, Ban‐Hock Toh	2002	15
14	Experimental Autoimmune Gastritis: Mouse Models Of Human Organ-specific Autoimmune Disease International Reviews of Immunology ·Judith Field, Mark Biondo, Kieran A. Murphy, Frank Alderuccio, B H Toh	2005	14
15	Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis The Journal of Pathology ·Mark Biondo, Judith Field, B‐H Toh, Frank Alderuccio	2006	13
16	Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques Thrombosis and Haemostasis ·Amy Searle, Yung‐Chih Chen, Maria Wallert, Xiaowei Wang, Hamid Hosseini, Karlheinz Peter, James D. McFadyen, Ana Maluenda, Jonathan Noonan, Peter Kanellakis, Maria T. K. Zaldivia, Angela Huang, Hadi Lioe, Mark Biondo, Marc W. Nolte, Paolo Rossato, Alex Bobik, Con Panousis	2021	12
17	CSL362: A Monoclonal Antibody to Human Interleukin-3 Receptor (CD123), Optimized for NK Cell-Mediated Cytotoxicity of AML Stem Cells Blood ·Samantha J. Busfield, Mark Biondo, Mae Wong, Hayley S. Ramshaw, Erwin M. Lee, Kirstee L. Martin, Souravi Ghosh, Hal Braley, Vesna Tomasetig, Con Panousis, G Vairo, Andrew W. Roberts, Simon He, Naomi S. Sprigg, Danièl Thomas, Mark DeWitte, Richard B. Lock, Angel F. López, Andrew D. Nash	2012	10
18	Pharmacodynamic Activity and Preclinical Safety of CSL362, a Novel Humanised, Affinity Matured Monoclonal Antibody Against Human Interleukin 3 Receptor Blood ·Eva Herzog, Samantha J. Busfield, Mark Biondo, G Vairo, Mark DeWitte, Ingo Pragst, Gerhard Dickneite, Andrew D. Nash, Sabine Zollner	2012	8
19	The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice Osteoarthritis and Cartilage ·Heonsu Shin, Varun Prasad, Tanya Lupancu, S. Malik, Adrian Achuthan, Mark Biondo, Bronwyn A. Kingwell, Manja Thiem, M. Gottschalk, Heike Weighardt, Irmgard Förster, Richard de Steiger, John A. Hamilton, Ming-Chin Lee	2023	6
20	Reversing the Autoimmune Condition: Experience with Experimental Autoimmune Gastritis International Reviews of Immunology ·Frank Alderuccio, Kim Murphy, Mark Biondo, Judith Field, Ban‐Hock Toh	2005	4

About Mark Biondo

Mark Biondo is a scholar working on Genetics, Gastroenterology, Hematology, Immunology and Transplantation, having authored 25 papers that have together received 702 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), CAR-T cell therapy research (3 papers) and Celiac Disease Research and Management (3 papers). The work is most often cited by research in Immunology and Allergy (163 citations), Hematology (165 citations), Immunology (297 citations), Dermatology (99 citations) and Gastroenterology (42 citations). Mark Biondo has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Frank Alderuccio, G Vairo, Samantha J. Busfield, Ban Hock Toh, Jennifer M. Rolland, Robyn E. O’Hehir, Maria P. de Leon, Belinda J. Hales, Alessandra Sandrini and John Aubrey Douglass. Their work appears in journals such as Blood, Leukemia, International Reviews of Immunology, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact